Cyanidin-3-O-glucoside counters the response to TNF-alpha of endothelial cells by activating Nrf2 pathway

Antonio Speciale1, Sirajudheen Anwar, Raffaella Canali

  • 1Department of Drug Sciences and Health Products, University of Messina, Messina, Italy.

Abstract

Insights

Cyanidin-3-O-glucoside (C3G) activates the Nrf2 pathway, enhancing antioxidant defenses and offering protection against vascular stress. This highlights C3G

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Cardiovascular Research

Background:

  • Dietary phytochemicals show disease prevention, but antioxidant effects alone don't fully explain in vivo benefits.
  • Specific genes regulated by the antioxidant responsive element (ARE) are influenced by antioxidants/electrophiles.
  • Phytochemicals may act as modulators of signal transduction pathways, offering a novel therapeutic avenue.

Purpose of the Study:

  • To investigate if cyanidin-3-O-glucoside (C3G) pharmacologically activates the Nrf2 pathway in vitro.
  • To determine C3G's role in its antiatherogenic effects.
  • To explore the involvement of signaling pathways in C3G's action.

Main Methods:

  • Investigated in vitro effects of C3G on human umbilical vein endothelial cells (HUVECs) stimulated with tumor necrosis factor-α (TNF-α).
  • Assessed oxidative stress, antioxidant systems, and Nrf2/ARE pathway activation.
  • Utilized mitogen-activated protein kinases (MAPKs) inhibitors (PD98059) to study pathway involvement.

Main Results:

  • C3G pretreatment prevented oxidative stress and enhanced antioxidant systems in HUVECs.
  • C3G activated the Nrf2/ARE pathway, involving ERK1/2 signaling.
  • ERK1/2 inhibition abolished C3G-induced Nrf2 nuclear accumulation and increased NF-κB p65 translocation.

Conclusions:

  • Natural Nrf2 and HO-1 inducers like C3G are potential therapeutic agents.
  • C3G demonstrates protective effects against vascular stressors.
  • These findings support C3G and similar phytochemicals for preventing pathological vascular conditions.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...